Larson Financial Group’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.68M Buy
12,065
+2,664
+28% +$373K 0.05% 253
2025
Q4
$1.15M Buy
9,401
+1,088
+13% +$132K 0.04% 296
2025
Q3
$923K Sell
8,313
-4,859
-37% -$552K 0.03% 325
2025
Q2
$1.46M Buy
13,172
+1,696
+15% +$180K 0.06% 248
2025
Q1
$1.29M Buy
11,476
+2,271
+25% +$234K 0.06% 236
2024
Q4
$850K Buy
9,205
+1,370
+17% +$123K 0.04% 269
2024
Q3
$657K Buy
7,835
+3,464
+79% +$264K 0.04% 287
2024
Q2
$300K Buy
4,371
+2,878
+193% +$192K 0.02% 361
2024
Q1
$109K Buy
1,493
+276
+23% +$21.2K 0.01% 523
2023
Q4
$98.6K Buy
1,217
+18
+2% +$1.4K 0.01% 488
2023
Q3
$89.8K Buy
1,199
+156
+15% +$12K 0.01% 473
2023
Q2
$80.3K Buy
1,043
+84
+9% +$6.7K 0.01% 454
2023
Q1
$79.5K Sell
959
-163
-15% -$13.5K 0.01% 461
2022
Q4
$96.3K Buy
1,122
+233
+26% +$18.5K 0.01% 409
2022
Q3
$55K Buy
889
+60
+7% +$3.78K 0.01% 450
2022
Q2
$51K Buy
829
+15
+2% +$929 0.01% 367
2022
Q1
$48K Buy
814
+9
+1% +$575 0.01% 383
2021
Q4
$58K Sell
805
-79
-9% -$5.44K 0.01% 359
2021
Q3
$62K Sell
884
-162
-15% -$11.4K 0.01% 264
2021
Q2
$72K Buy
1,046
+161
+18% +$10.8K 0.02% 219
2021
Q1
$57K Buy
885
+178
+25% +$11.5K 0.02% 231
2020
Q4
$41K Buy
707
+9
+1% +$543 0.01% 245
2020
Q3
$44K Buy
698
+2
+0.3% +$139 0.02% 218
2020
Q2
$54K Sell
696
-87
-11% -$6.67K 0.03% 187
2020
Q1
$59K Buy
783
+148
+23% +$10.2K 0.04% 149
2019
Q4
$41K Sell
635
-191
-23% -$12.4K 0.02% 166
2019
Q3
$52K Buy
826
+194
+31% +$12.7K 0.03% 145
2019
Q2
$43K Buy
632
+13
+2% +$855 0.03% 134
2019
Q1
$40K Buy
619
+6
+1% +$399 0.03% 127
2018
Q4
$38K Buy
+613
New +$42.8K 0.04% 123

Other funds holding GILD

Larson Financial Group's GILD Position: Q1 2026 in Review

Larson Financial Group increased its Gilead Sciences (GILD) stake by 28% in Q1 2026, buying an estimated $373K and bringing the position to 12,065 shares worth $1.68M. The position accounts for 0.05% of the portfolio, ranked #253.

Larson Financial Group first reported a position in GILD in Q4 2018 and has held it in 30 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Larson Financial Group held 12,065 shares of Gilead Sciences worth $1.68M as of Q1 2026.
  • Larson Financial Group bought 2,664 Gilead Sciences shares in Q1 2026, an estimated $373K.
  • Gilead Sciences made up 0.05% of Larson Financial Group's portfolio in Q1 2026, its #253 holding.
  • Larson Financial Group first reported a position in Gilead Sciences in Q4 2018 and has held it in 30 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.